Home » Newsletters » BioWorld Science

BioWorld Science

June 1, 2007

View Archived Issues

Takeda looks back on FY2006

Positive preclinical results with combined anthrax and plague vaccine

Clinical studies of drugs for digestive diseases

New therapeutic options for cancer imparted in recent patents

Recent Schering and Vertex patents describe novel therapeutic agents for respiratory disorders

Recent GSK patent discloses novel agents targeting hepatitis C virus infection

Clinical data on lisdexamfetamine in ADHD detailed

Pooled data show efficacy and safety of agomelatine in major depressive disorder

Recent clinical trials in urological cancer

LCP-Tacro delivers higher bioavailability compared to Prograf

First-in-class GABA-enhanced antipsychotic safe and well-tolerated in phase I study

Improved efficacy of PhGalpha1 demonstrated in new preclinical studies

NICE recommends use of Champix on U.K.'s National Health Service

Orlistat GSK recommended for approval in E.U.

XMT-1001 begins phase I study in solid tumors

Novacea and Schering-Plough sign license agreement for Asentar

CeNeRx licenses rights to PharmaNess cannabinoid portfolio

LymphoStat-B begins second phase III trial for SLE

XL-647 studied in new phase II NSCLC trial

Canadian approval for Thelin

Vernakalant (iv) filed in Canada

Aeras Global TB Vaccine Foundation updates TB vaccine development progress

Twice-daily Zyflo CR receives FDA approval

Vantas progresses through E.U. mutual recognition procedure

FDA approves new formulation of FazaClo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...